DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Gilead Sciences (NASDAQ: GILD)

105.96 0.03 (0.03%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $105.96 0.03%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $107.75
Previous Close $105.93
Daily Range $105.51 - $107.89
52-Week Range $58.81 - $110.64
Market Cap $160.2B
P/E Ratio 23.86
Dividend (Yield) $0.00 (0.0%)
Volume 22,211,004
Average Daily Volume 14,570,527
Current FY EPS $7.26





Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary

Dividend Aristocrats: Time to Buy AbbVie Inc Stock?

AbbVie is an innovative pharma company with an attractive yield and a strong outlook for top-line growth going forward. Here's why investors should dig into this top dividend stock.

VIVUS and Auxilium Announce Stendra Label Expansion - Analyst Blog

Bristol-Myers' (BMY) Yervoy Label Expanded in Canada - Analyst Blog

Incyte: Increasing Sales, Deep Pipeline, Multiple Catalysts, With A Side Of M&A Chatter

5 Things Gilead Sciences, Inc. Management Wants You to Know

Analysis of comments from Gilead Sciences' president and COO.

Gilead Emerging Market Agreement: Huge Win For Patients, Non-Event For Investors.

Sector Update: Health-Care Shares Lower in Pre-Market Trade

Sector Update: Health Care

US Stock Futures Signal Higher Start On Wall Street

Sanofi & MyoKardia Ink Deal to Develop Cardiomyopathies - Analyst Blog

See More GILD News...

GILD's Top Competitors

GILD $105.96 (0.03%)
Current stock: GILD
AMGN $144.01 (1.40%)
Current stock: AMGN
CELG $93.85 (0.62%)
Current stock: CELG
$0.00 (0.00%)
Current stock: